期刊
ACS MEDICINAL CHEMISTRY LETTERS
卷 10, 期 6, 页码 949-953出版社
AMER CHEMICAL SOC
DOI: 10.1021/acsmedchemlett.9b00114
关键词
IDO; immuno-oncology; SAR; lead optimization
A novel series of imidazoisoindoles were identified as potent indoleamine-2,3-dioxygenase (IDO) inhibitors. Lead optimization toward improving potency and eliminating CYP inhibition resulted in the discovery of lead compound 25, a highly potent IDO inhibitor with favorable pharmacokinetic properties. In the MC38 xenograft model in hPD-1 transgenic mice, 25 in combination with the anti PD-1 monoclonal antibody (SHR-1210) achieved a synergistic antitumor effect superior to each single agent.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据